Investment House LLC increased its stake in shares of Stericycle Inc. (NASDAQ:SRCL) by 6.1% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,455 shares of the company’s stock after buying an additional 1,750 shares during the period. Investment House LLC’s holdings in Stericycle were worth $3,171,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. LS Investment Advisors LLC boosted its stake in shares of Stericycle by 1.8% in the second quarter. LS Investment Advisors LLC now owns 4,745 shares of the company’s stock worth $494,000 after buying an additional 84 shares during the period. Dynamic Advisors Solutions LLC boosted its stake in shares of Stericycle by 1.7% in the first quarter. Dynamic Advisors Solutions LLC now owns 5,122 shares of the company’s stock worth $646,000 after buying an additional 85 shares during the period. Capstone Asset Management Co. boosted its stake in shares of Stericycle by 1.2% in the second quarter. Capstone Asset Management Co. now owns 7,613 shares of the company’s stock worth $793,000 after buying an additional 87 shares during the period. Cullinan Associates Inc. boosted its stake in shares of Stericycle by 0.5% in the second quarter. Cullinan Associates Inc. now owns 20,185 shares of the company’s stock worth $2,102,000 after buying an additional 100 shares during the period. Finally, Lazard Asset Management LLC boosted its stake in shares of Stericycle by 5.2% in the first quarter. Lazard Asset Management LLC now owns 2,608 shares of the company’s stock worth $329,000 after buying an additional 128 shares during the period. Institutional investors own 92.80% of the company’s stock.

Stericycle Inc. (NASDAQ:SRCL) traded up 1.29% on Wednesday, reaching $78.00. 1,254,100 shares of the company’s stock traded hands. Stericycle Inc. has a 12-month low of $76.76 and a 12-month high of $151.57. The stock has a market cap of $6.63 billion, a price-to-earnings ratio of 27.46 and a beta of 0.27. The stock has a 50 day moving average price of $84.48 and a 200 day moving average price of $102.42.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting the consensus estimate of $1.18. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. The business earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. During the same quarter in the previous year, the business posted $1.14 EPS. The company’s quarterly revenue was up 24.6% compared to the same quarter last year. Analysts forecast that Stericycle Inc. will post $4.67 EPS for the current year.

A number of equities research analysts have weighed in on SRCL shares. Imperial Capital cut their price objective on shares of Stericycle from $100.00 to $95.00 and set an “in-line” rating on the stock in a report on Thursday, May 26th. Royal Bank Of Canada restated a “sell” rating on shares of Stericycle in a report on Thursday, May 26th. Zacks Investment Research cut shares of Stericycle from a “hold” rating to a “sell” rating in a report on Tuesday, June 28th. Jefferies Group restated a “buy” rating and issued a $140.00 price objective on shares of Stericycle in a report on Monday, July 18th. Finally, Wellington Shields cut shares of Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $110.32.

In other news, Director Rodney F. Dammeyer sold 10,188 shares of the business’s stock in a transaction dated Wednesday, August 17th. The shares were sold at an average price of $85.50, for a total value of $871,074.00. Following the completion of the sale, the director now owns 10,188 shares in the company, valued at approximately $871,074. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Mark C. Miller sold 24,665 shares of the business’s stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $104.55, for a total transaction of $2,578,725.75. Following the completion of the sale, the director now owns 229,449 shares of the company’s stock, valued at approximately $23,988,892.95. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by insiders.

About Stericycle

Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.

5 Day Chart for NASDAQ:SRCL

Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.